Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis

Table 1 Changes of all observed parameters in patients with UC 24 h after admission (mean ± SD)

Group	n	PC (× 109/L)	GMP-140 (ug/L)	TXB2 (ng/L)	6-keto-PGF1a (ng/L)	1 min PAR (%)	VWF:Ag (%)
Normal control	30	158.2 ± 32.5	41.4 ± 10.2	68.4 ± 26.4	18.3 ± 6.8	38.6 ± 14.2	103.6 ± 23.7
Patients with UC	64	189.8 ± 68.3a	52.1 ± 17.8b	98.8 ± 55.4b	12.9 ± 8.2b	58.2 ± 21.5b	143.6 ± 52.7b
Remissive UC	25	173.7 ± 36.4c	48.4 ± 11.4ac	87.4 ± 32.7ac	14.5 ± 6.0a	47.8 ± 16.5ad	127.9 ± 46.1ac
Active UC	39	201.8 ± 48.6b	54.9 ± 13.2b	115.5 ± 46.8b	11.3 ± 6.4b	65.5 ± 19.2b	154.5 ± 48.9b

^aP < 0.05,

^bP < 0.01 vs normal control,

^cP < 0.05,

^dP < 0.01, vs active UC group.